Gene therapy of severe combined immunodeficiencies

被引:0
作者
Alain Fischer
Salima Hacein-Bey
Marina Cavazzana-Calvo
机构
[1] INSERM U429,
[2] Hôpital Necker,undefined
来源
Nature Reviews Immunology | 2002年 / 2卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The concept that the outcome of a devastating disease can be modified by inserting a transgene into abnormal cells is appealing. However, the gene-transfer technologies that are available at present have limited the success of gene therapy so far. Nevertheless, severe combined immunodeficiencies are a useful model, because gene transfer can confer a selective advantage to transduced cells. In this way, a proof of concept for gene therapy has been provided.
引用
收藏
页码:615 / 621
页数:6
相关论文
共 116 条
[1]  
Fischer A(2001)Primary immunodeficiencies: an experimental model for molecular medicine Lancet 357 1863-1869
[2]  
Buckley RH(1999)Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency N. Engl. J. Med. 340 508-516
[3]  
Haddad E(1999)Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: a single center study of 22 patients Blood 94 2923-2930
[4]  
Patel DD(2000)Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency N. Engl. J. Med. 342 1325-1332
[5]  
Blaese RM(1995)T-lymphocyte-directed gene therapy for ADA-SCID: initial trial result after 4 years Science 270 475-480
[6]  
Onodera M(1999)Sucessful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency Blood 91 30-36
[7]  
Bordignon C(1995)Gene therapy in peripheral-blood lymphocytes and bone marrow for ADA-immunodeficient patients: gene therapy in peripheral-blood lymphocytes and bone marrow for ADA-immunodeficient patients Science 270 470-475
[8]  
Kohn DB(1995)Engraftment of gene-modified umbilical-cord blood cells in neonates with adenosine deaminase deficiency Nature Med. 10 1017-1023
[9]  
Hoogerbrugge PM(1996)Bone-marrow gene transfer in three patients with adenosine deaminase deficiency Gene Ther. 3 179-183
[10]  
Cavazzana-Calvo M(2000)Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 669-672